SYNTHESIS AND HISTAMINE H-2 AGONISTIC ACTIVITY OF ARPROMIDINE ANALOGS - REPLACEMENT OF THE PHENIRAMINE-LIKE MOIETY BY NONHETEROCYCLIC GROUPS

被引:28
作者
BUSCHAUER, A [1 ]
FRIESEKIMMEL, A [1 ]
BAUMANN, G [1 ]
SCHUNACK, W [1 ]
机构
[1] TECH UNIV MUNICH, DEPT MED 1, DIV CARDIOL & CIRCULAT, W-8000 MUNICH 80, GERMANY
关键词
HISTAMINE; H-2; RECEPTOR; AGONIST; ARPROMIDINE; IMPROMIDINE; H-1; ANTAGONIST; ANTIHISTAMINE;
D O I
10.1016/0223-5234(92)90145-Q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Analogues of the potent histamine H-2 agonist arpromidine, characterized by non-heterocyclic groups (phenyl, cyclo-hexyl, alkyl) instead of the pheniramine-like portion, were prepared and tested for their H-2 agonistic and H-1 antagonistic activity in the isolated guinea pig right atrium and ileum, respectively. In the diphenylpropylguanidine series an increase in H-2 agonistic potency resulted from mono- or difluorination at one or both phenyl rings in the meta and/or para position (pD2 less-than-or-equal-to 7.75 vs pD2 = 7.15 for the unsubstituted parent compound). Compounds chlorinated at both phenyl rings were considerably less potent. Highest combined H-2 agonistic/H-1 antagonistic potency was found in the 4-fluorophenyl series. The arpromidine analogue with cyclohexyl and methyl group instead of phenyl and pyridine ring proved to be 30 times more potent than histamine in the atrium. The H-1 antagonistic potency in cyclohexyl compounds was lower than in the diaryl series. Thus, aromatic rings appear not to be required for high H-2 agonistic potency but are useful for combined H-2 agonistic/H-1 antagonistic activity.
引用
收藏
页码:321 / 330
页数:10
相关论文
共 44 条
  • [1] SUBSTITUTED 1,2,3,4-TETRAHYDROAMINONAPHTHOLS - ANTIHYPERTENSIVE AGENTS, CALCIUM-CHANNEL BLOCKERS, AND ADRENERGIC-RECEPTOR BLOCKERS WITH CATECHOLAMINE-DEPLETING EFFECTS
    ATWAL, KS
    OREILLY, BC
    RUBY, EP
    TURK, CF
    ABERG, G
    ASAAD, MM
    BERGEY, JL
    MORELAND, S
    POWELL, JR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (04) : 627 - 635
  • [2] BAUMANN G, 1988, INN MED, V15, P30
  • [3] POSSIBLE VALUE OF H-2-RECEPTOR AGONISTS FOR TREATMENT OF CATECHOLAMINE-INSENSITIVE CONGESTIVE HEART-FAILURE
    BAUMANN, G
    PERMANETTER, B
    WIRTZFELD, A
    [J]. PHARMACOLOGY & THERAPEUTICS, 1984, 24 (02) : 165 - 177
  • [4] APPARENT SUPERIORITY OF H-2-RECEPTOR STIMULATION AND SIMULTANEOUS BETA-BLOCKADE OVER CONVENTIONAL TREATMENT WITH BETA-SYMPATHOMIMETIC DRUGS IN POST-ACUTE MYOCARDIAL-INFARCTION - CARDIAC EFFECTS OF IMPROMIDINE - A NEW SPECIFIC H-2-RECEPTOR AGONIST - IN THE SURVIVING CATECHOLAMINE-INSENSITIVE MYOCARDIUMIC
    BAUMANN, G
    FELIX, SB
    HEIDECKE, CD
    RIESS, G
    LOHER, U
    LUDWIG, L
    BLOMER, H
    [J]. AGENTS AND ACTIONS, 1984, 15 (3-4): : 216 - 228
  • [5] DEFINITION AND ANTAGONISM OF HISTAMINE H2-RECEPTORS
    BLACK, JW
    PARSONS, EM
    DURANT, CJ
    DUNCAN, WAM
    GANELLIN, CR
    [J]. NATURE, 1972, 236 (5347) : 385 - &
  • [6] SYNTHESIS AND ADRENOCORTICAL INHIBITING ACTIVITY OF SUBSTITUTED DIPHENYLALKYLAMINES
    BLANK, B
    ZUCCARELLO, WA
    COHEN, SR
    FRISHMUTH, GJ
    SCARICACIOTTOLI, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1969, 12 (02) : 271 - +
  • [7] BOYLE F, 1984, Patent No. 122693
  • [8] THE LEUCKART REACTION WITH BETA-PHENYL KETONES
    BURCKHALTER, JH
    JOHNSON, SH
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (10) : 4830 - 4832
  • [9] BUSCHAUER A, 1991, AGENT ACTION SUPPL, V33, P231
  • [10] BUSCHAUER A, 1991, PHARMAZIE, V46, P840